Clinical Trial Update: Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Latisse to placebo for hypotrichosis of the eyebrows has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotrichosis

Drugs mentioned

• LATISSE (BIMATOPROST)

Snippet

Sponsor: Kenneth Beer | Conditions: Hypotrichosis | Phase 4 | Status: COMPLETED